SCHEMBL14101582

SCHEMBL14101582

c1ccc(-c2cccc(-c3ccc4ccc5c(-c6ccc7c(c6)sc6cc(-c8ccc9ccc%10c(-c%11cccc(-c%12ccccc%12)c%11)ccc%11ccc8c9c%11%10)ccc67)ccc6ccc3c4c65)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 1/20 0.39
PIK3CA P42336 1/20 0.39
PI4KA P42356 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
MAP3K8 P41279 2/20 0.37
F9 P00740 3/20 0.36
PIM3 Q86V86 1/20 0.35
MCL1 Q07820 1/20 0.35
ESR1 P03372 3/20 0.34
ESR2 Q92731 3/20 0.34
CYP1A2 P05177 2/20 0.34
ERBB2 P04626 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34
AHR P35869 1/20 0.34
HSD17B1 P14061 2/20 0.34
HSD17B2 P37059 2/20 0.34
MAPT P10636 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101629 1.00 LIMK1 (0.39) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101574 0.98 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101645 0.98 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101642 0.97 CYP1A2 (0.39) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101634 0.97 CYP1A2 (0.39) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101597 0.97 F9 (0.38) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101632 0.95 CYP1A2 (0.40) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101626 0.95 CYP1A2 (0.40) LIMK1PIK3CAPI4KAPI4KBMAP3K8
SCHEMBL14101627 0.95 LIMK1 (0.40) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL14101628 0.95 LIMK1 (0.40) LIMK1PIK3CAPI4KAPI4KBF9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR LIMK1 167/4885PIK3CA 4815/4885PI4KA 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.